Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald B Appel

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
BMC Nephrology|October 1, 2008
NPHS2 variation in focal and segmental glomerulosclerosisStephen J Tonna, Alexander Needham, Krishna Polu, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathiesLaura H Mariani, Sebastian Martini, Laura Barisoni, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal DysfunctionRichard A Lafayette, Pietro A Canetta, Brad H Rovin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2024
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after TransplantationBlanca Tarragón, Yonatan Peleg, Geetha Jagannathan, et al.
Nature Reviews. Nephrology|January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal diseaseRichard J H Smith, Gerald B Appel, Anna M Blom, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2005
Membranoproliferative glomerulonephritis type II (dense deposit disease): an updateGerald B Appel, H Terence Cook, Gregory Hageman, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
BMC Nephrology|October 1, 2008
NPHS2 variation in focal and segmental glomerulosclerosisStephen J Tonna, Alexander Needham, Krishna Polu, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathiesLaura H Mariani, Sebastian Martini, Laura Barisoni, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2016
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal DysfunctionRichard A Lafayette, Pietro A Canetta, Brad H Rovin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2024
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after TransplantationBlanca Tarragón, Yonatan Peleg, Geetha Jagannathan, et al.
Nature Reviews. Nephrology|January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal diseaseRichard J H Smith, Gerald B Appel, Anna M Blom, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2005
Membranoproliferative glomerulonephritis type II (dense deposit disease): an updateGerald B Appel, H Terence Cook, Gregory Hageman, et al.
Pageof 14